SCHEMBL1526033

SCHEMBL1526033

COc1ccc2c(C)c(C(=O)O)n(CCN3CCC(N)CC3)c2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.43
CNR2 P34972 2/20 0.43
TP53 P04637 2/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
RECQL P46063 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PLA2G10 O15496 1/20 0.41
KCNH2 Q12809 1/20 0.41
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
HTR2B P41595 2/20 0.40
PLA2G2A P14555 2/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
HRH2 P25021 2/20 0.40
CCNE2 O96020 1/20 0.40
CDK4 P11802 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1525703 0.82 KCNA3 (0.47) CNR1CNR2TP53KCNH2POLB
SCHEMBL4782432 0.81 KCNH2 (0.58) CNR1CNR2TP53ALDH1A1CYP1A2
SCHEMBL4781502 0.79 KCNH2 (0.44) CYP3A4KCNH2HTR2ACCNE2CDK4
SCHEMBL707054 0.77 ADRA1B (0.42) KCNH2CCNE2CDK4PRKACAPRKACG
SCHEMBL2797003 0.77 KCNH2 (0.45) CNR1CNR2ALDH1A1KCNH2CCNE2
Hydrochloric Acid SCHEMBL2799736 0.76 KCNH2 (0.44) CNR1CNR2ALDH1A1KCNH2CCNE2
SCHEMBL12002101 0.76 KCNH2 (0.47) ALDH1A1KCNH2CCNE2CDK4CCND1
SCHEMBL706526 0.74 MTNR1A (0.58) ALDH1A1CYP1A2KCNH2
SCHEMBL706949 0.74 KCNH2 (0.56) CYP3A4KCNH2
SCHEMBL4885587 0.74 PLA2G10 (0.64) CNR2TP53PLA2G10PLA2G2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2289890-A1 Compounds for the treatment of multi-drug resistant bacterial infections AstraZeneca AB (SE) 2011-03-02 EP disclosed